MediciNova, Inc.
General ticker "MNOV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $74.7M (TTM average)
MediciNova, Inc. follows the US Stock Market performance with the rate: 12.8%.
Estimated limits based on current volatility of 3.7%: low 1.33$, high 1.43$
Factors to consider:
- Total employees count: 13 as of 2024
- Top business risk factors: Operating losses, Clinical trial failures, Third-party risks, Manufacturing risks, Sales and marketing challenges
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.06$, 2.15$]
- 2026-12-31 to 2027-12-31 estimated range: [1.09$, 2.20$]
Financial Metrics affecting the MNOV estimates:
- Positive: with PPE of -5.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.82 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.63
- Positive: Shareholder equity ratio, % of 91.19 > 64.29
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term MNOV quotes
Long-term MNOV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.00MM | $0.00MM | $0.41MM |
| Operating Expenses | $10.90MM | $12.68MM | $13.69MM |
| Operating Income | $-9.90MM | $-12.68MM | $-13.28MM |
| Non-Operating Income | $1.33MM | $1.63MM | $1.29MM |
| R&D Expense | $5.66MM | $7.19MM | $7.15MM |
| Income(Loss) | $-8.57MM | $-11.04MM | $-11.99MM |
| Taxes | $0.00MM | $0.01MM | $0.01MM |
| Profit(Loss)* | $-8.57MM | $-11.05MM | $-12.00MM |
| Stockholders Equity | $62.38MM | $52.50MM | $41.59MM |
| Assets | $66.27MM | $55.88MM | $45.60MM |
| Operating Cash Flow | $-7.43MM | $-10.64MM | $-9.81MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $39.91MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $0.02MM | $0.00MM | $0.24MM |
| Earnings Per Share** | $-0.17 | $-0.23 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.